RxDoctor Payments DataLook up a doctor →

Pamela Palmer, APRN

Family · Kearney, NENPI 1205298023

Payments from drug & device makers

$5,264in general payments, 2019–2025

Across 287 payments — averaging $18.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Neurocrine Biosciences, Inc.$665
  • Biogen$398
  • Lilly USA, LLC$266
  • Teva Pharmaceuticals USA, Inc.$217
  • Argenx US, Inc.$191
  • plus $2K from 45 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,264 in reported general payments places this provider in the 95th percentile of 809 family providers in Nebraska.

See all family providers in Nebraska

Medicare billing

Part B allowed, 2024
$55,650
Medicare patients
244
Services billed
4,399

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Kearney

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →